Prohost Letter #390

Prohost Letter #390
COMPANIES USING CRISPR GENE EDITING TOOLS - The Firms Launched with CRISPR Patents Either Pending or Disputed!
What Does This Mean?
What are these Firms’ Priorities?
But First: A Reminder

In the last issue, Prohost #389, we pinpointed the gene editing technologies and techniques and demonstrated the difference between gene editing, which is genetic engineering, i.e., making changes in the genes themselves, and antisense editing, which edits the malfunctioning genes’ messages before the mRNA (the messenger) delivers the to the factory in order to execute the messages according to instructions, producing malfunctioning disease-causing proteins . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.